NASDAQ: SLDBSolid Biosciences Inc Stock Ownership - Who owns Solid Biosciences?
Insider buying vs selling
Have Solid Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Alexander Cumbo | President and CEO | 2026-02-18 | 16,644 | $5.82 | $96.92kSell |
| Jessie Hanrahan | Chief Regulatory Officer | 2026-02-18 | 4,134 | $5.82 | $24.07kSell |
| Ilan Ganot | Director | 2026-02-18 | 2,658 | $5.82 | $15.48kSell |
| David T. Howton | Chief Operating Officer | 2026-02-18 | 7,469 | $5.82 | $43.49kSell |
| Paul Herzich | Chief Technology Officer | 2026-02-18 | 3,616 | $5.82 | $21.06kSell |
| Kevin Tan | CFO Treasurer | 2026-02-18 | 5,404 | $5.82 | $31.47kSell |
| Jessie Hanrahan | Chief Regulatory Officer | 2026-02-04 | 12,348 | $6.44 | $79.55kSell |
| Gabriel Brooks | Chief Medical Officer | 2026-02-04 | 12,616 | $6.44 | $81.27kSell |
| Alexander Cumbo | President and CEO | 2026-02-04 | 48,913 | $6.44 | $315.10kSell |
| Ilan Ganot | Director | 2026-02-04 | 7,205 | $6.44 | $46.41kSell |
SLDB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SLDB insiders and whales buy or sell their stock.
SLDB Shareholders
What type of owners hold Solid Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Rajeev M. Shah | 13.49% | 13,281,046 | $107.05M | Insider |
| Perceptive Advisors LLC | 12.09% | 11,906,646 | $95.97M | Institution |
| Ra Capital Management LP | 11.79% | 11,608,856 | $93.57M | Insider |
| Bain Capital Life Sciences Investors LLC | 9.96% | 9,808,819 | $79.06M | Institution |
| Ra Capital Management LP | 9.49% | 9,339,978 | $75.28M | Institution |
| Ultragenyx Pharmaceutical Inc | 7.95% | 7,825,797 | $63.08M | Insider |
| Siren LLC | 7.81% | 7,690,405 | $61.98M | Institution |
| Gilad David Hayeem | 5.22% | 5,136,501 | $41.40M | Insider |
| Bain Capital Life Sciences Investors LLC | 5.11% | 5,034,582 | $40.58M | Insider |
| Vestal Point Capital LP | 5.08% | 5,000,000 | $40.30M | Institution |
SLDB vs Biotech Stocks
Solid Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.